Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis
Original Article
J.S. Smolen, E. Feist, S. Fatenejad, S.A. Grishin, E.V. Korneva, E.L. Nasonov, M.Y. Samsonov, and R.M. Fleischmann
N Engl J Med 2022;387:715-726
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, August 25, 2024 - 11:59pm.